Astrazeneca drags down the FTSE 100 following mixed cancer trial results
Shares in Astrazenca and Daiichi Sankyo nose dived today after the pair revealed mixed results in their lung cancer drug's ...
Astra, Daiichi Drop on Mixed Lung Cancer Drug Trial Result
Daiichi Sankyo Co. shares drop as much as 10.4% on Tuesday, the most since Aug. 5, after its lung cancer drug with ...
BMW suffers £3.7bn slump over major problems with brakes
BMW will recall about 1.5m vehicles over problems with their brakes, wiping €4.3bn (£3.7bn) off the value of the German ...
Morning Scan: All the big stories to get you started for the day
Start your day ahead of the curve with our sharp, curated morning news roundup. Get the key stories from top newspapers and ...
Push Square3d
Sony Priming 'Even Less Exciting' PS5 Remaster for State of Play
It sounds like Sony’s upcoming State of Play – widely expected to be broadcast on 24th September although still technically unannounced – could bring news of an “even less exciting” remaster than ...
Harris Associates Japan Strategy Q2 2024 Commentary
Harris Associates Japan Strategy portfolio’s return was -6.59% (net) vs. MSCI Japan Index (Net) that returned -4.27% for the ...
money.rediff4d
Northern Arc Capital IPO Subscribed 9.98 Times
Northern Arc Capital's IPO received strong investor interest, getting subscribed 9.98 times on Day 2. The share sale received bids for 21,43,97,349 shares against 2,14,78,290 shares on offer.